<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Ashbya-Riboflavin-Fermentation on 生物经济</title><link>https://cn.bioecon.ru/technologies/ashbya-riboflavin-fermentation/</link><description>Recent content in Ashbya-Riboflavin-Fermentation on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Sun, 05 Jul 2026 21:54:07 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/technologies/ashbya-riboflavin-fermentation/index.xml" rel="self" type="application/rss+xml"/><item><title>维生素（D3、B族、抗坏血酸）</title><link>https://cn.bioecon.ru/technology/vitamins-d3-b-group-ascorbic-acid/</link><pubDate>Sun, 05 Jul 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/vitamins-d3-b-group-ascorbic-acid/</guid><description>工业规模维生素生产——B族维生素通过直接发酵、维生素C通过葡萄糖两步生物转化、维生素D3通过紫外光化学法——大宗抗坏血酸生产高度集中于中国，而欧盟则保留了核黄素及稳定性工程化饲料预混料的独特发酵产能。</description></item></channel></rss>